Other News

Last week marked the launch of the EBC statement “Counting down to zero: Towards a future with underfunded health research?”, which calls on the European Commission, the European Parliament and the Council of the European Union to increase the budget of the 9th Framework Programme of Research & Innovation, or “Horizon Europe”, to at least €120 billion.

Prof. F. Fazekas, President of the EAN and Prof. W. Struhal President of EFAS are pleased to announce that: EAN has joined with EFAS to promote Autonomic Nervous System (ANS) disorders in Europe and advance optimal care and management for… Continue Reading

EFNA member association Dystonia Europe was among the winners of the Brain, Mind, and Pain Patient-Centred Innovation Grant, announced on Wednesday in Brussels.

GAMIAN-Europe, a patient-driven pan-European organization, represents the interests of persons affected by mental illness and advocates their right www.gamian.eu   GAMIAN Europe: European Parliament Interest Group on Mental Health, Well-being and Brain Disorders European Parliament, Brussels, Belgium, 16 May 2018… Continue Reading

On the occasion of the ninth European Conference on Rare Diseases & Orphan Products (ECRD) held in Vienna on 10th-12th May 2018, Prof. Marc Dooms, main author of the Declaration on Good Off-Label Use Practices (GOLUP), presented the 5 criteria for using medicines off-label that are laid down in the declaration. Many participants showed an interest in the declaration as well as various initiatives organized within the framework of the GOLUP-campaign.

WFN website: www.wfneurology.org Adress for the WBD: wbd2018@wfneurology.org. Clean air for brain health Mohammad Wasay MD, FRCP, FAAN (Aga Khan University, Karachi, Pakistan)
Wolfgang Grisold MD (Secretary General, WFN, Vienna, Austria) A link between environment and health has long been… Continue Reading

Last week EFNA attended the 4th European Academy of Neurology (EAN) Congress in Lisbon, along with more than 6700 neurologists! Once again, EFNA took this opportunity to bring together our members for our annual General Assembly. On Day 1 we… Continue Reading

        by Anna Sauerbier         Digital medicine and treatment development for brain disorders AZ, Lilly pull plug on Alzheimer’s disease trials France builds first Alzheimer’s ‘village’ in pioneering experiment Horizon Europe budget not big… Continue Reading

Prof. G. Deuschl, President of the EAN and Prof. W. Wick President of EANO are pleased to announce that: EAN has joined with EANO to promote optimal management of neuro-oncological care in neurology in Europe.

Dear Colleague, We seek your help in identifying candidates for the € 1 million prize, The Brain Prize, which is awarded by the Lundbeck Foundation. The Brain Prize recognizes highly original and influential advances in research on the nervous system,… Continue Reading

David B. Vodušek (DBV): Mr Bundgaard-Nielsen, you have been director of the Lundbeck Foundation. Can you explain to our readers the facts about this foundation and its relations to Lundbeck, the well known pharmaceutical company? Mogens Bundgaard-Nielsen (MBN): The Lundbeck Foundation was established in 1954 by Grete Lundbeck. She was the widow after Hans Lundbeck, the founder of the company H. Lundbeck who died some 10 years earlier. She eventually

        by Anna Sauerbier         EPD introduces Massive Open Online Course (MOOC) on “Introduction to Cognitive Behavioural Therapy” Mental health policy: What progress are we making? How can we create sustainable healthcare systems? MasterMind:… Continue Reading

  The year’s BRAIN prize was awarded to Professors Bart de Strooper (Leuven),Christian Haass (Munich), Michael Goedert (Cambridge) and John Hardy (London) for their groundbreaking research on the genetic and molecular basis of Alzheimer’s disease, with far-reaching implications for the… Continue Reading

Patients with cardiovascular dysautonomia often develop neurogenic supine hypertension, that is hypertension while lying, even in the presence of severe blood pressure falls upon standing, i.e. orthostatic hypotension. Neurogenic supine hypertension has been linked to chronic end-organ damage, as well… Continue Reading

  2017 was a remarkable year for EBC, thanks to the development of an increasing number of activities and new initiatives. In particular, the publication of EBC’s policy white paper on the “Value of Treatment for Brain Disorders in Europe”… Continue Reading